CA Stock MarketDetailed Quotes

APS Aptose Biosciences Inc

Watchlist
  • 0.420
  • +0.180+75.00%
15min DelayMarket Closed Dec 20 16:00 ET
25.00MMarket Cap-0.11P/E (TTM)

About Aptose Biosciences Inc Company

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Company Profile

SymbolAPS
Company NameAptose Biosciences Inc
Founded2006
MarketTSE
Employees36
Fiscal Year Ends12-31
Address251 Consumers Road Suite 1105
CityToronto
CountryCAN
Zip CodeM2J 4R3
Phone+1 647 479-9828

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William G. Rice, PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 924.67K
  • Dr. Rafael Bejar, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 750.08K
  • Fletcher Payne
  • Principal Accounting Officer, Senior Vice President, Chief Financial Officer, Corporate Secretary and Chief Business Officer
  • 611.37K
  • Carol Gail Ashe
  • Independent Director
  • 123.67K
  • Warren Whitehead
  • Independent Director
  • 122.68K
  • Dr. Mark D. Vincent, M.D.
  • Independent Director
  • 127.68K
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • 132.17K
  • Dr. Erich M. Platzer, M.D.,PhD
  • Independent Director
  • 123.67K
  • Dr. Denis R. Burger,PhD
  • Lead Independent Director
  • 172.17K
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.